Percutaneous pulmonary artery denentation completely abolishes experimental pulmonary arterial hypertension in vivo
Percutaneous pulmonary artery denentation completely abolishes experimental pulmonary arterial hypertension in vivo
复制标题
DOI:
10.4244/eijv9i2a43
复制
发表时间:
2013-06-01
期刊:
影响因子:
6.2
通讯作者:
Kwan, Tak W.
中科院分区:
文献类型:
--
作者:
Chen, Shao-Liang;Zhang, Yao-Jun;Kwan, Tak W.
Aims: The study sought to assess the effect of percutaneous pulmonary artery denervation (PADN) on balloon-occlusion-induced acute pulmonary arterial hypertension (PAH) in vivo. The PADN is a minimally invasive and endovascular catheter-based interventional therapy using radiofrequency ablation to abolish the pulmonary arterial baroreceptors to pressure response.Methods and results: To examine the efficacy of balloon-occlusion-induced PAH, twenty Mongolian dogs were randomly assigned to one of two groups: group 1 (left distal pulmonary basal trunk occlusion) and group 2 (left pulmonary interlobar artery occlusion). Afterwards, PADN treatment at the main pulmonary artery bifurcation level with left pulmonary interlobar artery occlusion in all 20 dogs was conducted. Haemodynamic parameters were measured at baseline and during balloon occlusion as well as the PADN treatment at different time points: one, two, three, five, and ten minutes. Before the PADN treatment, most haemodynamic parameters of the pulmonary artery remained unchanged in group 1 with distal pulmonary basal trunk occlusion. However, in group 2 with the occlusion of the left pulmonary interlobar artery, mean pulmonary arterial pressure, mean right ventricular pressure, and pulmonary vessel resistance gradually increased, and mean absolute difference reached peak at five minutes (Delta 16.6 mmHg, Delta 14.1 mmHg and Delta 1,144 dye/s/cm(5), respectively; each p